218 related articles for article (PubMed ID: 31900337)
1. Vinpocetine Suppresses
Komatsu K; Nam DH; Lee JY; Yoneda G; Yan C; Li JD
J Immunol; 2020 Feb; 204(4):933-942. PubMed ID: 31900337
[TBL] [Abstract][Full Text] [Related]
2. Vinpocetine inhibits Streptococcus pneumoniae-induced upregulation of mucin MUC5AC expression via induction of MKP-1 phosphatase in the pathogenesis of otitis media.
Lee JY; Komatsu K; Lee BC; Miyata M; O'Neill Bohn A; Xu H; Yan C; Li JD
J Immunol; 2015 Jun; 194(12):5990-8. PubMed ID: 25972475
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway.
Lee J; Komatsu K; Lee BC; Lim JH; Jono H; Xu H; Kai H; Zhang ZJ; Yan C; Li JD
J Biol Chem; 2012 Jun; 287(27):22799-811. PubMed ID: 22610099
[TBL] [Abstract][Full Text] [Related]
4. TLR2 promotes macrophage recruitment and Streptococcus pneumoniae clearance during mouse otitis media.
Huang Y; Wang Z; Jin C; Wang L; Zhang X; Xu W; Xiang Y; Wang W; He X; Yin Y; He Y
Pediatr Res; 2016 Dec; 80(6):886-893. PubMed ID: 27463737
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling.
Koga T; Lim JH; Jono H; Ha UH; Xu H; Ishinaga H; Morino S; Xu X; Yan C; Kai H; Li JD
J Biol Chem; 2008 May; 283(18):12546-54. PubMed ID: 18332137
[TBL] [Abstract][Full Text] [Related]
6. CYLD negatively regulates nontypeable Haemophilus influenzae-induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK.
Wang WY; Komatsu K; Huang Y; Wu J; Zhang W; Lee JY; Miyata M; Xu H; Li JD
PLoS One; 2014; 9(11):e112516. PubMed ID: 25389768
[TBL] [Abstract][Full Text] [Related]
7. Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media.
Short KR; von Köckritz-Blickwede M; Langereis JD; Chew KY; Job ER; Armitage CW; Hatcher B; Fujihashi K; Reading PC; Hermans PW; Wijburg OL; Diavatopoulos DA
Infect Immun; 2014 Jan; 82(1):364-70. PubMed ID: 24191297
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.
Tong HH; Lambert G; Li YX; Thurman JM; Stahl GL; Douthitt K; Clancy C; He Y; Bowman AS
PLoS One; 2014; 9(4):e95160. PubMed ID: 24740152
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 17A promotes pneumococcal clearance by recruiting neutrophils and inducing apoptosis through a p38 mitogen-activated protein kinase-dependent mechanism in acute otitis media.
Wang W; Zhou A; Zhang X; Xiang Y; Huang Y; Wang L; Zhang S; Liu Y; Yin Y; He Y
Infect Immun; 2014 Jun; 82(6):2368-77. PubMed ID: 24664502
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Streptococcus pneumoniae otitis media in a chinchilla model by transtympanic delivery of antibiotics.
Yang R; Sabharwal V; Shlykova N; Okonkwo OS; Pelton SI; Kohane DS
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282835
[TBL] [Abstract][Full Text] [Related]
11. Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.
Li Q; Li YX; Stahl GL; Thurman JM; He Y; Tong HH
Infect Immun; 2011 Jul; 79(7):2578-85. PubMed ID: 21502587
[TBL] [Abstract][Full Text] [Related]
12. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media.
Keller LE; Bradshaw JL; Pipkins H; McDaniel LS
Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973
[TBL] [Abstract][Full Text] [Related]
13. TBX21 participates in innate immune response by regulating Toll-like receptor 2 expression in Streptococcus pneumoniae infections.
Woo CH; Shin SG; Koh SH; Lim JH
Mol Oral Microbiol; 2014 Oct; 29(5):233-43. PubMed ID: 24903905
[TBL] [Abstract][Full Text] [Related]
14. Otitis media: the chinchilla model.
Giebink GS
Microb Drug Resist; 1999; 5(1):57-72. PubMed ID: 10332723
[TBL] [Abstract][Full Text] [Related]
15. Glycolytic Metabolism Is Critical for the Innate Antibacterial Defense in Acute
Fan F; Ma Y; Ai R; Ding Z; Li D; Zhu Y; He Q; Zhang X; Dong Y; He Y
Front Immunol; 2021; 12():624775. PubMed ID: 33953708
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of linezolid in experimental otitis media.
Pelton SI; Figueira M; Albut R; Stalker D
Antimicrob Agents Chemother; 2000 Mar; 44(3):654-7. PubMed ID: 10681334
[TBL] [Abstract][Full Text] [Related]
17. Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media.
Habets MN; van Selm S; van Opzeeland FJ; Simonetti E; Hermans PWM; de Jonge MI; Diavatopoulos DA
Vaccine; 2016 Nov; 34(48):5968-5974. PubMed ID: 27771185
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of cytokine genes and inducible nitric oxide synthase induced by opacity phenotype variants of Streptococcus pneumoniae during acute otitis media in the rat.
Long JP; Tong HH; Shannon PA; DeMaria TF
Infect Immun; 2003 Oct; 71(10):5531-40. PubMed ID: 14500471
[TBL] [Abstract][Full Text] [Related]
19. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
Sabirov A; Metzger DW
Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
[TBL] [Abstract][Full Text] [Related]
20. Development of a non-invasive murine infection model for acute otitis media.
Stol K; van Selm S; van den Berg S; Bootsma HJ; Blokx WAM; Graamans K; Tonnaer ELGM; Hermans PWM
Microbiology (Reading); 2009 Dec; 155(Pt 12):4135-4144. PubMed ID: 19762437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
